VanEck Biotech ETF (BBH)
158.56
+2.01
(+1.28%)
USD |
NASDAQ |
Dec 20, 16:00
Price Chart
Key Stats
| Net Expense Ratio | Discount or Premium to NAV | Total Assets Under Management | 30-Day Average Daily Volume |
|---|---|---|---|
| -- | -- | -- | -- |
| Dividend Yield | Turnover Ratio | 1 Year Fund Level Flows | Max Drawdown (Since Inception) |
| -- | Upgrade | -- | Upgrade |
Basic Info
| Investment Strategy | |
| General | |
| Security Type | |
| Broad Asset Class | |
| Broad Category | |
| Global Peer Group | |
| Peer Group | |
| Global Macro | |
| US Macro | |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | |
| Fund Owner Firm Name | |
| Broad Asset Class Benchmark Index | |
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of December 22, 2024.
Asset Allocation
| Type | % Net | % Long | % Short |
|---|---|---|---|
| Cash | -- | -- | -- |
| Stock | -- | -- | -- |
| Bond | -- | -- | -- |
| Convertible | -- | -- | -- |
| Preferred | -- | -- | -- |
| Other | -- | -- | -- |
Basic Info
| Investment Strategy | |
| General | |
| Security Type | |
| Broad Asset Class | |
| Broad Category | |
| Global Peer Group | |
| Peer Group | |
| Global Macro | |
| US Macro | |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | |
| Fund Owner Firm Name | |
| Broad Asset Class Benchmark Index | |